• 21 Hits
  • Search Condition : Filter (MeSH = B7-H1 Antigen / metabolism)
Species Resource Title
Human and Animal Cells T24(RCB2536) , JMSU1(RCB2227) STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-γ-induced Apoptosis in Urothelial Cancer.
DNA material pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) Whole-genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in adult T-cell leukemia/lymphoma.
Human and Animal Cells HEV0271 The Detection of Immunity against WT1 and SMAD4P130L of EpCAM+ Cancer Cells in Malignant Pleural Effusion.
Human and Animal Cells HSC-2(RCB1945) , HSC-3(RCB1975) , HSC-4(RCB1902) Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer.
Human and Animal Cells PANC-1(RCB2095) Reduction of HIF-1α/PD-L1 by Catalytic Topoisomerase Inhibitor Induces Cell Death Through Caspase Activation in Cancer Cells Under Hypoxia.
Human and Animal Cells II-18(RCB2093) Regulation of PD-L1 expression in non-small cell lung cancer by interleukin-1β.
Human and Animal Cells Sq-1979(RCB0284) Local Low-dose Anti-PD-L1 Antibodies Improve Antitumor Effects in Oral Squamous Cell Carcinoma.
Human and Animal Cells TE-8(RCB2098) PD-L1-expressing cancer-associated fibroblasts induce tumor immunosuppression and contribute to poor clinical outcome in esophageal cancer.
Human and Animal Cells Sq-1979(RCB0284) An In Vivo Study of Local Administration of Low-dose Anti-PD-1 Antibody Using an Oral Cancer Cell Line.
Human and Animal Cells OP9(RCB1124) , OP9/G-DLL1(RCB2925) In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
Mice RBRC02142 Evaluation of therapeutic PD-1 antibodies by an advanced single-molecule imaging system for human PD-1 microclusters
Human and Animal Cells TGBC2TKB(RCB1130) GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancer.
Human and Animal Cells RAJI(RCB1647) PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity.
Human and Animal Cells C2C12(RCB0987) , B16F10(RCB2630) Extracellular acidity in tumor tissue upregulates programmed cell death protein 1 expression on tumor cells via proton-sensing G protein-coupled receptors.
Human and Animal Cells OV2944-HM-1(RCB1483) Intratumoral Delivery of an Adenoviral Vector Carrying the SOCS-1 Gene Enhances T-Cell-Mediated Antitumor Immunity By Suppressing PD-L1.
Human and Animal Cells TE-1(RCB1894) Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer.
Human and Animal Cells DAUDI(RCB1640) PD-L1 expression enhancement by infiltrating macrophage-derived tumor necrosis factor-α leads to poor pancreatic cancer prognosis.
Human and Animal Cells PC-9(RCB4455) Soluble PD-L1 with PD-1-binding capacity exists in the plasma of patients with non-small cell lung cancer.
Human and Animal Cells PC-9(RCB4455) Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation.
Human and Animal Cells OV2944-HM-1(RCB1483) PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction.